Nath Bio-Genes (India) (BOM:537291) YoY EBITDA Growth : -32.24% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Nath Bio-Genes (India) YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Nath Bio-Genes (India)'s YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -32.24%.

Nath Bio-Genes (India)'s EBITDA per Share for the three months ended in Mar. 2024 was ₹1.49.

Nath Bio-Genes (India) YoY EBITDA Growth Historical Data

The historical data trend for Nath Bio-Genes (India)'s YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nath Bio-Genes (India) YoY EBITDA Growth Chart

Nath Bio-Genes (India) Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

24.41

19.84

-174.44

198.16

2.41

Nath Bio-Genes (India) Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															103.82	7.18	-9.17	0.67	-32.24

Nath Bio-Genes (India) YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Nath Bio-Genes (India)'s YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(26.567	-	25.941)	/	\| 25.941 \|
=	2.41 %

Nath Bio-Genes (India)'s YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(1.494	-	2.205)	/	\| 2.205 \|
=	-32.24 %

Nath Bio-Genes (India) YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Nath Bio-Genes (India)'s YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Nath Bio-Genes (India) (BOM:537291) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Nath Bio-Genes (India) Ltd (BOM:537291) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

NATHBIOGEN:India

Address

Nath House, Nath Road, Chhatrapati Sambhajinagar, MH, IND, 431005

Website

https://www.nathbiogenes.com

Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.

Nath Bio-Genes (India) (BOM:537291) Headlines

No Headlines